Reportedly, a bench of Delhi High Court temporarily allowed Xiaomi to sell a few of its devices in India about a week after the suspension of its sales in the third-largest smartphone market of the world. Xiaomi as well as…
The applicant, in this case, is M/s Air Master Equipments India (P) Ltd and Respondents are: Mr Ramesh Nana Mhatre, who is the inventor and Applicant of the granted patent application being discussed, and Controller of Patents who granted the…
In the latest update, Novartis has sued Cipla for infringing its patents on “Onbrez” (Indacaterol) after Cipla launched its generic version for Indacaterol in October claiming “urgent unmet need” for the drug in India. Earlier, as we have reported here,…
As reported in TOI, the Indian Government has found very little merit in Cipla’s plea for waiver and cancellation of Patent rights for chronic obstructive pulmonary disease (COPD) drug over which Novartis has exclusive rights. We have reported on Cipla’s…
In CS(OS) 3775/2014, as we understand from multiple sources, Xiaomi has been injuncted from manufacturing its line of smartphones for it has been prima-facie found to be infringing on certain standard-essential patents of Ericsson. Although the order is not uploaded…
It has been recently reported in Economic times that Cipla has filed representation with the government (Department of Industrial Policy & Promotion) seeking revocation of five patents of Novartis on indacaterol, a respiratory drug for the treatment of chronic obstructive…
We have earlier reported the release of Draft Guidelines for Examination of Pharma Patent Applications. The Patent Office has now released revised draft guidelines and in continuation of our earlier article here, we explain herein what those revisions are and…
With a significantly increasing number of Individual Inventors and Small/Medium Sized Clients regularly asking on the Patent Registration Process in India, this article is an effort by our Intern, Ananya Singh, to come up with a quick article on Patent…
Recently, Controller General of Patents Design and Trade Marks, Mr. Chaitanya Prasad, has issued a Public Notice on August 7, 2014, wherein it has been put forth that, from August 1, 2014, Official Fees for filing a new Trade Mark…
In a major setback, the Indian Patent Office denied a patent to an anti-cancer drug Abraxane manufactured by US-Based Abraxis BioSciences. Here we will discuss the decision given by IPO at the backdrop of the arguments advanced by the respective…